(CEG) Constellation Energy - Overview
Stock: Electricity, Natural Gas, Renewable Energy
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.54% |
| Yield on Cost 5y | 3.82% |
| Yield CAGR 5y | 40.13% |
| Payout Consistency | 100.0% |
| Payout Ratio | 21.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 58.8% |
| Relative Tail Risk | -14.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.14 |
| Alpha | -40.52 |
| Character TTM | |
|---|---|
| Beta | 1.748 |
| Beta Downside | 1.828 |
| Drawdowns 3y | |
|---|---|
| Max DD | 50.70% |
| CAGR/Max DD | 0.91 |
Description: CEG Constellation Energy January 27, 2026
Constellation Energy Corporation (NASDAQ: CEG) is a U.S.-based utility that generates, markets, and sells electricity and natural gas across five geographic segments-Mid-Atlantic, Midwest, New York, ERCOT, and Other Power Regions. Its customer base spans regulated distribution utilities, municipalities, cooperatives, and a mix of commercial, industrial, public-sector, and residential end-users.
As of the latest Q4 2025 filing, CEG reported total operating revenue of $4.2 billion, an adjusted EPS of $1.08, and a net cash position of $2.1 billion. The firm now operates roughly 31,676 MW of capacity, with the generation mix tilted toward nuclear (≈45 % of capacity) and natural-gas peakers (≈30 %), while wind, solar, and hydro together account for the remaining ≈25 %. Capacity utilization in Q4 2025 averaged 71 %, reflecting higher demand in the Midwest and ERCOT regions.
Key economic drivers include (1) the regional capacity-market revenue model, which ties earnings to Federal Energy Regulatory Commission (FERC) price-cap adjustments; (2) exposure to natural-gas price volatility, mitigated by long-term contracts covering ~60 % of gas-fuelled generation; and (3) the accelerating state renewable-portfolio standards that are prompting incremental investments in wind and solar-CEG added 1.2 GW of renewable capacity in 2025, a 15 % year-over-year increase.
For a deeper, data-rich assessment of CEG’s valuation and risk profile, consult the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 2.74b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA 13.31 > 1.0 |
| NWC/Revenue: 16.48% < 20% (prev 15.92%; Δ 0.56% < -1%) |
| CFO/TA 0.04 > 3% & CFO 2.42b > Net Income 2.74b |
| Net Debt (4.95b) to EBITDA (6.03b): 0.82 < 3 |
| Current Ratio: 1.56 > 1.5 & < 3 |
| Outstanding Shares: last quarter (314.0m) vs 12m ago 0.0% < -2% |
| Gross Margin: 19.43% > 18% (prev 0.21%; Δ 1923 % > 0.5%) |
| Asset Turnover: 47.14% > 50% (prev 46.27%; Δ 0.87% > 0%) |
| Interest Coverage Ratio: 8.70 > 6 (EBITDA TTM 6.03b / Interest Expense TTM 488.0m) |
Altman Z'' 1.71
| A: 0.07 (Total Current Assets 11.65b - Total Current Liabilities 7.46b) / Total Assets 56.16b |
| B: 0.10 (Retained Earnings 5.59b / Total Assets 56.16b) |
| C: 0.08 (EBIT TTM 4.25b / Avg Total Assets 54.00b) |
| D: 0.35 (Book Value of Equity 14.35b / Total Liabilities 41.47b) |
| Altman-Z'' Score: 1.71 = BBB |
Beneish M -2.10
| DSRI: 2.02 (Receivables 3.78b/1.76b, Revenue 25.45b/23.98b) |
| GMI: 1.07 (GM 19.43% / 20.70%) |
| AQI: 0.96 (AQ_t 0.40 / AQ_t-1 0.42) |
| SGI: 1.06 (Revenue 25.45b / 23.98b) |
| TATA: 0.01 (NI 2.74b - CFO 2.42b) / TA 56.16b) |
| Beneish M-Score: -2.10 (Cap -4..+1) = BB |
What is the price of CEG shares?
Over the past week, the price has changed by -6.86%, over one month by -26.27%, over three months by -25.50% and over the past year by -15.69%.
Is CEG a buy, sell or hold?
- StrongBuy: 10
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CEG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 402.2 | 53.8% |
| Analysts Target Price | 402.2 | 53.8% |
| ValueRay Target Price | 309.1 | 18.2% |
CEG Fundamental Data Overview February 07, 2026
P/E Forward = 22.2717
P/S = 3.6032
P/B = 6.3233
P/EG = 3.6314
Revenue TTM = 25.45b USD
EBIT TTM = 4.25b USD
EBITDA TTM = 6.03b USD
Long Term Debt = 7.27b USD (from longTermDebt, last quarter)
Short Term Debt = 1.77b USD (from shortTermDebt, last quarter)
Debt = 9.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.95b USD (from netDebt column, last quarter)
Enterprise Value = 94.45b USD (89.51b + Debt 9.04b - CCE 4.09b)
Interest Coverage Ratio = 8.70 (Ebit TTM 4.25b / Interest Expense TTM 488.0m)
EV/FCF = -342.2x (Enterprise Value 94.45b / FCF TTM -276.0m)
FCF Yield = -0.29% (FCF TTM -276.0m / Enterprise Value 94.45b)
FCF Margin = -1.08% (FCF TTM -276.0m / Revenue TTM 25.45b)
Net Margin = 10.76% (Net Income TTM 2.74b / Revenue TTM 25.45b)
Gross Margin = 19.43% ((Revenue TTM 25.45b - Cost of Revenue TTM 20.51b) / Revenue TTM)
Gross Margin QoQ = 23.72% (prev 18.00%)
Tobins Q-Ratio = 1.68 (Enterprise Value 94.45b / Total Assets 56.16b)
Interest Expense / Debt = 1.48% (Interest Expense 134.0m / Debt 9.04b)
Taxrate = 33.41% (466.0m / 1.40b)
NOPAT = 2.83b (EBIT 4.25b * (1 - 33.41%))
Current Ratio = 1.56 (Total Current Assets 11.65b / Total Current Liabilities 7.46b)
Debt / Equity = 0.63 (Debt 9.04b / totalStockholderEquity, last quarter 14.35b)
Debt / EBITDA = 0.82 (Net Debt 4.95b / EBITDA 6.03b)
Debt / FCF = -17.92 (negative FCF - burning cash) (Net Debt 4.95b / FCF TTM -276.0m)
Total Stockholder Equity = 13.48b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.07% (Net Income 2.74b / Total Assets 56.16b)
RoE = 20.32% (Net Income TTM 2.74b / Total Stockholder Equity 13.48b)
RoCE = 20.46% (EBIT 4.25b / Capital Employed (Equity 13.48b + L.T.Debt 7.27b))
RoIC = 12.84% (NOPAT 2.83b / Invested Capital 22.01b)
WACC = 11.32% (E(89.51b)/V(98.54b) * Re(12.36%) + D(9.04b)/V(98.54b) * Rd(1.48%) * (1-Tc(0.33)))
Discount Rate = 12.36% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -0.94%
Fair Price DCF = unknown (Cash Flow -276.0m)
EPS Correlation: 54.68 | EPS CAGR: -8.83% | SUE: -2.32 | # QB: 0
Revenue Correlation: 26.48 | Revenue CAGR: 7.22% | SUE: 0.40 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.58 | Chg30d=-0.108 | Revisions Net=-2 | Analysts=4
EPS next Year (2026-12-31): EPS=11.54 | Chg30d=+0.116 | Revisions Net=+0 | Growth EPS=+23.4% | Growth Revenue=+6.2%